Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

03/08/2021 05:30

Aug 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.45               18.07            79.20    
                 (+2.1 pct)          (-19.1 pct)      (+5.6 pct)  
  Operating          4.42                5.03            18.80    
                 (-12.1 pct)         (-25.0 pct)      (+5.7 pct)  
  Recurring          4.66                5.25            19.20    
                 (-11.2 pct)         (-23.9 pct)      (+5.4 pct)  
  Net                3.36                3.82            14.00    
                 (-12.0 pct)         (-20.8 pct)      (+4.4 pct)  
  EPS             87.78 yen           98.18 yen       367.47 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T